mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.3 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.067 |
0.3 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |